Circulating NT-proBNP is glycosylated in severe human heart failure patients

被引:0
|
作者
Hammerer-Lercher, A.
Halfinger, B.
Sarg, B.
Mair, L.
Puschendorf, B.
Griesmacher, A.
Guzman, N. N.
Lindner, H. H.
机构
[1] Innsbruck Med Univ, Innsbruck Bioctr, Dept Med Chem Diagnost, Div Clin Biochem, Innsbruck, Austria
[2] Innsbruck Bioctr, Div Clin Biochem, Innsbruck, Austria
[3] Dept Internal Med, Clin Div Cardiol, Innsbruck, Austria
[4] Dept Med & Chem Diagnost, Innsbruck, Austria
关键词
D O I
暂无
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A63
引用
收藏
页码:A20 / A20
页数:1
相关论文
共 50 条
  • [1] Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure
    Hammerer-Lercher, Angelika
    Halfinger, Bernhard
    Sarg, Bettina
    Mair, Johannes
    Puschendorf, Bernd
    Griesmacher, Andrea
    Guzman, Norberto A.
    Lindner, Herbert H.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (05) : 858 - 865
  • [2] Immunodetection of glycosylated NT-proBNP circulating in human blood
    Seferian, Karina R.
    Tamm, Natalia N.
    Semenov, Alexander G.
    Tolstaya, Anastasia A.
    Koshkina, Ekaterina V.
    Krasnoselsky, Mihail I.
    Postnikov, Alexander B.
    Serebryanaya, Daria V.
    Apple, Fred S.
    Murakarni, MaryAnn M.
    Katrukha, Alexey G.
    [J]. CLINICAL CHEMISTRY, 2008, 54 (05) : 866 - 873
  • [3] NT-proBNP in severe chronic heart failure: rationale, design and preliminary results of the COPERNICUS NT-proBNP substudy
    Hartmann, F
    Packer, M
    Coats, AJS
    Fowler, MB
    Krum, H
    Mohacsi, P
    Rouleau, JL
    Tendera, M
    Castaigne, A
    Trawinski, J
    Amann-Zalan, I
    Hoersch, S
    Katus, HA
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2004, 6 (03) : 343 - 350
  • [4] Stability of NT-ProBNP in patients with systolic heart failure
    Jimenez-Navarro, Manuel F.
    Fernandez-Moyano, Maria A.
    Dominguez-Franco, Antonio
    Gomez-Doblas, Juan J.
    Molero, Encarnacion
    Gomez-Hernandez, Gemma
    Morell, Miguel
    de Teresa-Galvan, Eduardo
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2006, 59 (10): : 1075 - 1078
  • [5] Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
    Anna Cabré
    Pilar Valdovinos
    Iolanda Lázaro
    Gil Bonet
    Alfredo Bardají
    Lluís Masana
    [J]. Cardiovascular Diabetology, 12
  • [6] Parallel evolution of circulating FABP4 and NT-proBNP in heart failure patients
    Cabre, Anna
    Valdovinos, Pilar
    Lazaro, Iolanda
    Bonet, Gil
    Bardaji, Alfredo
    Masana, Lluis
    [J]. CARDIOVASCULAR DIABETOLOGY, 2013, 12
  • [7] Predictors of NT-proBNP response in primary care patients with heart failure and NT-proBNP guided therapy
    Erntell, H.
    Swedberg, K.
    Jorgensen, L.
    Dahlstrom, U.
    Persson, H.
    [J]. EUROPEAN JOURNAL OF HEART FAILURE, 2013, 12 : S31 - S31
  • [8] COMPARATIVE EVALUATION OF COPEPTIN AND NT-PROBNP IN PATIENTS WITH SEVERE ACUTE DECOMPENSATED HEART FAILURE
    Zhang Dongying
    Jia Jun
    Chen Jia
    Qin Shu
    [J]. HEART, 2013, 99 : E220 - E221
  • [9] Effect of growth hormone treatment on circulating levels of NT-proBNP in patients with ischemic heart failure
    Karason, Kristjan
    Bobbio, Emanuele
    Polte, Christian
    Bollano, Entela
    Peterson, Magnus
    Cittadini, Antonio
    Caidahl, Kenneth
    Hjalmarson, Ake
    Bengtsson, Bengt-Ake
    Ekelund, Jan
    Swedberg, Karl
    Isgaard, Jorgen
    [J]. GROWTH HORMONE & IGF RESEARCH, 2020, 55
  • [10] Variability of NT-ProBNP levels in patients with stable heart failure
    Araujo, J. P.
    Azevedo, A.
    Lourenco, P.
    Ferreira, A.
    Goncalves, F. Rocha
    Bettencourt, P.
    [J]. EUROPEAN HEART JOURNAL, 2006, 27 : 208 - 209